Weise Danielle O, Kruk Monica E, Higgins LeeAnn, Markowski Todd W, Jagtap Pratik D, Mehta Subina, Mickelson Alan, Parker Laurie L, Wendt Christine H, Griffin Timothy J
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Medical School, University of Minnesota, Minneapolis, MN, USA.
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Clin Proteomics. 2023 Apr 2;20(1):14. doi: 10.1186/s12014-023-09404-1.
Clinical bronchoalveolar lavage fluid (BALF) samples are rich in biomolecules, including proteins, and useful for molecular studies of lung health and disease. However, mass spectrometry (MS)-based proteomic analysis of BALF is challenged by the dynamic range of protein abundance, and potential for interfering contaminants. A robust, MS-based proteomics compatible sample preparation workflow for BALF samples, including those of small and large volume, would be useful for many researchers.
We have developed a workflow that combines high abundance protein depletion, protein trapping, clean-up, and in-situ tryptic digestion, that is compatible with either qualitative or quantitative MS-based proteomic analysis. The workflow includes a value-added collection of endogenous peptides for peptidomic analysis of BALF samples, if desired, as well as amenability to offline semi-preparative or microscale fractionation of complex peptide mixtures prior to LC-MS/MS analysis, for increased depth of analysis. We demonstrate the effectiveness of this workflow on BALF samples collected from COPD patients, including for smaller sample volumes of 1-5 mL that are commonly available from the clinic. We also demonstrate the repeatability of the workflow as an indicator of its utility for quantitative proteomic studies.
Overall, our described workflow consistently provided high quality proteins and tryptic peptides for MS analysis. It should enable researchers to apply MS-based proteomics to a wide-variety of studies focused on BALF clinical specimens.
临床支气管肺泡灌洗(BAL)液样本富含包括蛋白质在内的生物分子,对肺部健康和疾病的分子研究很有用。然而,基于质谱(MS)的BALF蛋白质组学分析受到蛋白质丰度动态范围以及潜在干扰污染物的挑战。一种适用于BALF样本(包括小体积和大体积样本)的、稳健的、与基于MS的蛋白质组学兼容的样本制备工作流程,对许多研究人员来说将是有用的。
我们开发了一种工作流程,该流程结合了高丰度蛋白质去除、蛋白质捕获、净化和原位胰蛋白酶消化,与基于定性或定量MS的蛋白质组学分析兼容。如果需要,该工作流程还包括用于BALF样本肽组学分析的内源性肽的增值收集,以及在LC-MS/MS分析之前对复杂肽混合物进行离线半制备或微量分级分离的适用性,以增加分析深度。我们证明了该工作流程对从慢性阻塞性肺疾病(COPD)患者收集的BALF样本的有效性,包括对临床常见的1-5 mL较小样本体积的有效性。我们还证明了该工作流程的可重复性,作为其在定量蛋白质组学研究中实用性的一个指标。
总体而言,我们描述的工作流程始终为MS分析提供高质量的蛋白质和胰蛋白酶肽。它应使研究人员能够将基于MS的蛋白质组学应用于广泛的针对BALF临床标本的研究。